BioTime Announces Third Quarter 2012 Financial Results and Recent Corporate Accomplishments

Published: Nov 12, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter and year-to-date period ended September 30, 2012 and highlighted recent corporate accomplishments.

Back to news